<DOC>
	<DOCNO>NCT00881257</DOCNO>
	<brief_summary>The objective clinical investigation evaluate safety efficacy Minnow Medical GRST™ Peripheral Catheter System treatment de novo lesion superficial femoral artery ( SFA ) popliteal artery .</brief_summary>
	<brief_title>Multicenter Assessment Safety Efficacy Minnow Medical GRST™ Peripheral Catheter System</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . Patient ≥18 age . 2 . Patient Rutherford category 24 . 3 . De novo single lesion diameter stenosis ( % DS ) ≥50 % 4 . Target lesion de novo occlusion successfully predilated result lesion &lt; 99 % . 5 . Target lesion stenosis length ≤100 mm base visual assessment . 6 . Target vessel reference diameter ≥3.0 mm ≤7.0 mm base visual assessment . 7 . Angiographic evidence distal runoff define minimum one patent tibial artery straight flow foot . 8 . Patient willing able provide write informed consent prior study specific procedure . 9 . Patient willing able comply specify followup evaluation specify time . 1 . Prior PTA intend target lesion include 10 mm proximal distal intend treatment area . 2 . Evidence thrombus target vessel . 3 . Prior ipsilateral contralateral low limb arterial bypass . 4 . Treatment ipsilateral lesion index procedure plan treatment index procedure . 5 . Target lesion severely calcify . 6 . Any known allergy / intolerance follow : ASA , Clopidogrel , Heparin , contrast agent ( adequately premedicated ) . 7 . Any planned surgery within 30 day study procedure . 8 . Renal failure ( serum creatinine &gt; 2.0 mg/dL ) . 9 . Female childbearing potential without negative pregnancy test . 10 . Patient organ transplant . 11 . Patient currently participate investigational drug device study reach primary endpoint yet clinically interfere endpoint study . 12 . In investigator 's opinion , patient severe comorbid condition ( ) could limit ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Radiofrequency</keyword>
</DOC>